Skip to content
DefDex

Federal award

HIKMA PHARMACEUTICALS USA INC.

0114

Contract

Obligated and Ceiling

Obligated (net)
$128,905.20
Ceiling (potential value, not spending)
—
Current value
—
Gross positive obligations
$128,905.20

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
HIKMA PHARMACEUTICALS USA INC. · NQJ5E87TKNB1
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
HIKMA AMERICAS INC. · K8FJFV1PF6R1
Awarding agency
Department of Defense · sub-agency 97AS · office SPM2D0
Funding agency
Department of Defense · sub-agency 97AS
Product or service (PSC)
6505 · DRUGS AND BIOLOGICALS
Industry (NAICS)
325411 · MEDICINAL AND BOTANICAL MANUFACTURING
PIID
0114
Parent vehicle (IDV PIID)
SPM2D007D0004
Award type code
C
Actions
1 · Oct 21, 2011 to Oct 21, 2011
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History1

Award actions
DateFYModAction typeObligationCompany in company totals
Oct 21, 2011FY20120—$128,905.20
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.